5792917
Last Update Posted: 2023-09-13
Recruiting has ended
Males accepted | 18 Years-65 Years |
166 Estimated Participants | No Expanded Access |
Interventional Study | Accepts healthy volunteers |
Bioequivalence Study of Tafolecimab Injections in Chinese Healthy Male Volunteers
This trial is conducted in China. The purpose of this study is to evaluate the pharmacokinetic similarity of Tafolecimab with different manufacturing process in healthy male subjects. Another purpose is to determine safety, and immunogenicity of sintilimab with different manufacturing process,also to determine Pharmacodynamics of Tafolecimab with different manufacturing process
Eligibility
Relevant conditions:
Healthy Male Subjects
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov